Processing

Please wait...

Settings

Settings

Goto Application

1. WO2022011215 - METHOD AND SYSTEM FOR SALIVA TESTING FOR VIRUS INCLUDING COVID-19

Publication Number WO/2022/011215
Publication Date 13.01.2022
International Application No. PCT/US2021/041016
International Filing Date 09.07.2021
IPC
C12Q 1/70 2006.1
CCHEMISTRY; METALLURGY
12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
1Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
70involving virus or bacteriophage
C12Q 1/6809 2018.1
CCHEMISTRY; METALLURGY
12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
1Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
68involving nucleic acids
6809Methods for determination or identification of nucleic acids involving differential detection
C12Q 1/6806 2018.1
CCHEMISTRY; METALLURGY
12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
1Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
68involving nucleic acids
6806Preparing nucleic acids for analysis, e.g. for polymerase chain reaction assay
C12Q 1/6888 2018.1
CCHEMISTRY; METALLURGY
12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
1Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
68involving nucleic acids
6876Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
6888for detection or identification of organisms
Applicants
  • THE ROCKEFELLER UNIVERSITY [US]/[US]
  • DARNELL, Robert B.
Inventors
  • DARNELL, Robert B.
Agents
  • HARRINGTON, James F.
  • HENNEBERGER, Glenn, T.
  • GALLAGHER, John, T.
  • BENNETT, Anthony, E.
  • ZUSCHLAG, Steven, T.
Priority Data
63/050,15510.07.2020US
63/135,15908.01.2021US
63/135,22408.01.2021US
63/171,74907.04.2021US
Publication Language English (en)
Filing Language English (EN)
Designated States
Title
(EN) METHOD AND SYSTEM FOR SALIVA TESTING FOR VIRUS INCLUDING COVID-19
(FR) MÉTHODE ET SYSTÈME DE TEST DE SALIVE POUR UN VIRUS Y COMPRIS LA COVID-19
Abstract
(EN) The present invention provides methods for rapid and efficient isolation and characterization of nucleic acid, particularly RNA, from small volume and self-collected samples, particularly saliva samples, to determine the presence or absence of infectious agent RNA, particularly viral RNA, particularly infectious viral RNA, particularly coronavirus. The invention provides methods for isolation and evaluation of infectious agent RNA from saliva samples, particularly viral agents, particularly coronavirus. The invention further provides methods and strategies for pooling samples and RNA to determine the presence or absence of infectious agent RNA, particularly viral RNA, particularly infectious viral RNA, particularly coronavirus, with regard to large numbers of samples at one time and in a single pooled test format.
(FR) La présente invention concerne des méthodes d'isolement et de caractérisation rapides et efficaces d'acide nucléique, en particulier de l'ARN, à partir d'échantillons de faible volume et auto-prélevés, en particulier d'échantillons de salive, pour déterminer la présence ou l'absence d'ARN d'agent infectieux, en particulier d'ARN viral, en particulier d'ARN viral infectieux, en particulier de coronavirus. L'invention concerne des méthodes d'isolement et d'évaluation d'ARN d'agent infectieux à partir d'échantillons de salive, en particulier d'agents viraux, en particulier de coronavirus. L'invention concerne en outre des méthodes et des stratégies pour regrouper des échantillons et de l'ARN pour déterminer la présence ou l'absence d'ARN d'agent infectieux, en particulier d'ARN viral, en particulier d'ARN viral infectieux, en particulier de coronavirus, en ce qui concerne de grands nombres d'échantillons à la fois et dans un seul format de test commun.
Latest bibliographic data on file with the International Bureau